CDKI-83 is a potent inhibitor of CDK9 and CDK1, exhibiting anti-proliferative activity in human tumor cell lines (GI50 < 1 μM); it effectively induces apoptosis in A2780 human ovarian cancer cells; by inhibiting CDK9 activity, it reduces Ser-2 phosphorylation of RNA polymerase II (RNAPII) and downregulates Mcl-1 and Bcl-2; it holds potential for anticancer research.